Publications 2022

Alavi A, Saboury B, Nardo L, Zhang V, Wang MY, Li HD, Raynor WY, Werner TJ, Hoilund-Carlsen PF, Revheim ME (2022)
Potential and Most Relevant Applications of Total Body PET/CT Imaging
Clin. Nucl. Med., 47 (1), 43-55
DOI 10.1097/RLU.0000000000003962

Publications 2021

Alavi A, Werner TJ, Raynor W, Hoilund-Carlsen PF, Revheim ME (2021)
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting
Am. J. Nucl. Med. Molec. Imaging, 11 (5), 337-351

Arani LS, Zadeh MZ, Saboury B, Revheim ME, Oestergaard B, Borja AJ, Samarin DS, Seraj SM, Kalbush E, Ayubcha C, Morris MA, Werner TJ, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2021)
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using F-18- sodium fluoride PET/CT
J. Nucl. Cardiol., 28 (6), 3044-3054
DOI 10.1007/s12350-020-02446-0

Ayubcha C, Moghbel M, Borja AJ, Newberg A, Werner TJ, Alavi A, Revheim ME (2021)
Tau Imaging in Head Injury
PET Clin., 16 (2), 249-260
DOI 10.1016/j.cpet.2020.12.009

Ayubcha C, Raynor WY, Borja AJ, Seraj SM, Rojulpote C, Werner TJ, Revheim ME, Rajapakse CS, Alavi A (2021)
Magnetic resonance imaging-based partial volume-corrected F-18-sodium fluoride positron emission tomography in the femoral neck
Nucl. Med. Commun., 42 (4), 416-420
DOI 10.1097/MNM.0000000000001344

Ayubcha C, Revheim ME, Newberg A, Moghbel M, Rojulpote C, Werner TJ, Alavi A (2021)
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
Eur. J. Nucl. Med. Mol. Imaging, 48 (2), 623-641
DOI 10.1007/s00259-020-04926-4

Borja AJ, Hancin EC, Raynor WY, Ayubcha C, Detchou DK, Werner TJ, Revheim ME, Alavi A (2021)
A Critical Review of PET Tracers Used for Brain Tumor Imaging
PET Clin., 16 (2), 219-231
DOI 10.1016/j.cpet.2020.12.004

Borja AJ, Hancin EC, Zhang V, Koa B, Bhattaru A, Rojulpote C, Detchou DK, Aly M, Kaghazchi F, Gerke O, Patil S, Gonuguntla K, Werner TJ, Revheim ME, Hoilund-Carlsen PF, Alavi A (2021)
Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
Nucl. Med. Commun., 42 (4), 444-450
DOI 10.1097/MNM.0000000000001349

Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordoy I, Macpherson ME, Aukrust P, Jorgensen SF, Aalokken TM, Fevang B (2021)
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and F-18-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front. Immunol., 11, 617985
DOI 10.3389/fimmu.2020.617985

Hancin EC, Raynor WY, Borja AJ, Werner TJ, Revheim ME, Alavi A (2021)
Non-F-18-FDG/F-18-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
PET Clin., 16 (2), 273-284
DOI 10.1016/j.cpet.2020.12.005

Hernes E, Revheim ME, Hole KH, Tulipan AJ, Stromme H, Lilleby W, Seierstad T (2021)
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard A Systematic Review and Meta-Analysis
PET Clin., 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001

Hole KH, Tulipan AJ, Reijnen JS, Hernes E, Vlatkovic L, Lie AK, Revheim ME, Seierstad T (2021)
Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Am. J. Nucl. Med. Molec. Imaging, 11 (5), 387-+

Jahangiri P, Dreyfuss AD, Duan FH, Snyder BS, Borja AJ, Pournazari K, Kothekar E, Arani L, Al-Zaghal A, Seraj SM, Hancin EC, Pinheiro B, Werner TJ, Swisher-McClure S, Feigenberg SJ, Torigian DA, Revheim ME, Simone CB, Alavi A (2021)
Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
Am. J. Nucl. Med. Molec. Imaging, 11 (5), 415-427

Kaghazchi F, Borja AJ, Hancin EC, Bhattaru A, Detchou DKE, Seraj SM, Rojulpote C, Hess S, Nardo L, Gabriel PE, Damrauer SM, Werner TJ, Alavi A, Revheim ME (2021)
Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation
Am. J. Nucl. Med. Molec. Imaging, 11 (2), 99-106

Koa B, Borja AJ, Aly M, Padmanabhan S, Tran J, Zhang V, Rojulpote C, Pierson SK, Tamakloe MA, Khor JS, Werner TJ, Fajgenbaum DC, Alavi A, Revheim ME (2021)
Emerging role of 18F-FDG PET/CT in Castleman disease: a review
Insights Imaging, 12 (1), 35
DOI 10.1186/s13244-021-00963-1

Koa B, Borja AJ, Yellanki D, Rojulpote C, Tran J, Zhang V, Werner TJ, Alavi A, Revheim ME (2021)
F-18-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am. J. Nucl. Med. Molec. Imaging, 11 (1), 1-+

Londalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2021)
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of Lu-177-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur. J. Nucl. Med. Mol. Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x

Lynch C, Reguilon I, Langer DL, Lane D, De P, Wong WL, Mckiddie F, Ross A, Shack L, Win T, Marshall C, Revheim ME, Danckert B, Butler J, Dizdarevic S, Louzado C, Mcgivern C, Hazlett A, Chew C, O'connell M, Harrison S (2021)
A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study
Int. J. Qual. Health Care, 33 (1), mzaa166
DOI 10.1093/intqhc/mzaa166

Muller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME (2021)
Evaluation of semi-quantitative measures of F-18-Flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant. Imaging Med. Surg.
DOI 10.21037/qims-21-188

Paydary K, Revheim ME, Emamzadehfard S, Gholami S, Pourhassan S, Werner TJ, Hoilund-Carlsen PF, Alavi A (2021)
Quantitative thoracic aorta calcification assessment by(18)F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age
Eur. Radiol., 31 (2), 785-794
DOI 10.1007/s00330-020-07133-9

Rana MU, Osthus AA, Heimdal K, Jebsen P, Revheim MER, Osnes TA (2021)
Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment
Acta Oto-Laryngol., 141 (3), 303-308
DOI 10.1080/00016489.2020.1845397

Raynor WY, Borja AJ, Hancin EC, Werner TJ, Alavi A, Revheim ME (2021)
Novel Musculoskeletal and Orthopedic Applications of F-18-Sodium Fluoride PET
PET Clin., 16 (2), 295-311
DOI 10.1016/j.cpet.2020.12.006

Raynor WY, Park PSU, Borja AJ, Sun YS, Werner TJ, Ng SJ, Lau HC, Hoilund-Carlsen PF, Alavi A, Revheim ME (2021)
PET-Based Imaging with F-18-FDG and F-18-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
Diagnostics, 11 (12), 2234
DOI 10.3390/diagnostics11122234

Revheim ME, Alavi A (2021)
PET-based Novel Imaging Techniques with Recently Introduced Radiotracers Preface
PET Clin., 16 (2), XV-XVI
DOI 10.1016/j.cpet.2021.01.001

Revheim ME, Hole KH, Mo T, Bruland OS, Reitan E, Julsrud L, Seierstad T (2021)
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
Acta Radiol., 02841851211027389
DOI 10.1177/02841851211027389

Rigney G, Ayubcha C, Werner TJ, Alavi A, Revheim ME (2021)
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Clin. Transl. Imaging
DOI 10.1007/s40336-021-00466-5

Rogne AG, Muller EG, Udnaes E, Sigurdardottir S, Raudeberg R, Connelly JP, Revheim ME, Hassel B, Dehlberg D (2021)
beta-Amyloid may accumulate in the human brain after focal bacterial infection: An F-18-flutemetamol positron emission tomography study
Eur. J. Neurol., 28 (3), 877-883
DOI 10.1111/ene.14622

Seierstad T, Hole KH, Tulipan AJ, Stromme H, Lilleby W, Revheim ME, Hernes E (2021)
F-18-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard A Systematic Review
PET Clin., 16 (2), 167-176
DOI 10.1016/j.cpet.2020.12.012

Tulipan AJ, Salberg UB, Hole KH, Vlatkovic L, Aarnes EK, Revheim ME, Lyng H, Seierstad T (2021)
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer
Am. J. Nucl. Med. Molec. Imaging, 11 (4), 250-+

Publications 2020

Aksnes M, Muller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojevic V, Bogdanovic N, Knapskog AB (2020)
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J. Alzheimers Dis., 77 (2), 831-842
DOI 10.3233/JAD-200237

Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
F-18-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am. J. Nucl. Med. Molec. Imaging, 10 (1), 66-73

Borja AJ, Hancin EC, Zhang V, Revheim ME, Alavi A (2020)
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
Eur. J. Nucl. Med. Mol. Imaging, 47 (11), 2493-2498
DOI 10.1007/s00259-020-04697-y

Johnsrud K, Seierstad T, Russell D, Revheim ME (2020)
Inter-reader agreement of F-18-FDG PET/CT for the quantification of carotid artery plaque inflammation
JRSM CARDIOVASC. DIS., 9, 2048004020980941
DOI 10.1177/2048004020980941

Kothekar E, Revheim ME, Borja AJ, Hancin EC, Detchou DK, Werner TJ, Shin DB, Gelfand JM, Alavi A (2020)
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system
Am. J. Nucl. Med. Molec. Imaging, 10 (5), 265-271

Kothekar E, Yellanki D, Borja AJ, Al-zaghal A, Werner TJ, Revheim ME, Gerke O, Saboury B, Gholamrezanezad A, Hoilund-Carlsen PF, Alavi A (2020)
F-18-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology
Nucl. Med. Commun., 41 (2), 162-168
DOI 10.1097/MNM.0000000000001127

Mayer M, Borja AJ, Hancin EC, Auslander T, Revheim ME, Moghbel MC, Werner TJ, Alavi A, Rajapakse CS (2020)
Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
Front. Physiol., 11, 511391
DOI 10.3389/fphys.2020.511391

Mirzaei S, Revheim ME, Raynor W, Zehetner W, Knoll P, Zandieh S, Alavi A (2020)
Cu-64-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
Oncol. Ther., 8 (1), 125-131
DOI 10.1007/s40487-019-00104-1

Mouminah A, Borja AJ, Hancin EC, Chang YC, Werner TJ, Swisher-McClure S, Korostoff J, Alavi A, Revheim ME (2020)
F-18-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
Eur. J. Hybrid Imag., 4 (1), 22
DOI 10.1186/s41824-020-00091-x

Seraj SM, Raynor WY, Revheim ME, Al-Zaghal A, Zadeh MZ, Arani LS, Rojulpote C, Werner TJ, Gerke O, Hoilund-Carlsen PF, Baker JF, Alavi A, Hunt SJ (2020)
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
Ann. Nucl. Med., 34 (6), 424-431
DOI 10.1007/s12149-020-01463-w

Shamchi SP, Zadeh MZ, Ostergaard B, Kim J, Raynor WY, Khosravi M, Taghvaei R, Nielsen AL, Gerke O, Werner TJ, Holdgaard P, Abildgaard N, Revheim ME, Hoilund-Carlsen PF, Alavi A (2020)
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
Nucl. Med. Commun., 41 (3), 288-293
DOI 10.1097/MNM.0000000000001144

Zadeh MZ, Ostergaard B, Raynor WY, Revheim ME, Seraj SM, Acosta-Montenegro O, Ayubcha C, Yellanki DP, Al-Zaghal A, Nielsen AL, Constantinescu CM, Gerke O, Werner TJ, Zhuang HM, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
Comparison of F-18-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
Eur. J. Nucl. Med. Mol. Imaging, 47 (12), 2846-2855
DOI 10.1007/s00259-020-04768-0

Zadeh MZ, Raynor WY, Ostergaard B, Hess S, Yellanki DP, Ayubcha C, Seraj SM, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang HM, Revheim ME, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
Correlation of whole-bone marrow dual-time-point F-18-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am. J. Nucl. Med. Molec. Imaging, 10 (5), 257-264

Zadeh MZ, Seraj SM, Ostergaard B, Mimms S, Raynor WY, Aly M, Borja AJ, Arani LS, Gerke O, Werner TJ, Zhuang HM, Revheim ME, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
Prognostic significance of F-18-sodium fluoride in newly diagnosed multiple myeloma patients
Am. J. Nucl. Med. Molec. Imaging, 10 (4), 151-160

Zhang V, Borja AJ, Rojulpote C, Padmanabhan S, Patil S, Gonuguntla K, Revheim ME, Werner TJ, Hoilund-Carlsen PF, Alavi A (2020)
Global quantification of pulmonary artery atherosclerosis using F-18-sodium fluoride PET/CT in at-risk subjects
Am. J. Nucl. Med. Molec. Imaging, 10 (2), 119-126

Zhang V, Koa B, Borja AJ, Padmanhabhan S, Bhattaru A, Raynor WY, Rojulpote C, Seraj SM, Werner TJ, Rajapakse C, Alavi A, Revheim ME (2020)
Diagnosis and Monitoring of Osteoporosis with Total-Body F-18-Sodium Fluoride-PET/CT
PET Clin., 15 (4), 487-496
DOI 10.1016/j.cpet.2020.06.011

Publications 2019

Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME (2019)
F-18-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
J. Nucl. Cardiol., 26 (3), 883-893
DOI 10.1007/s12350-017-1121-7

Kothekar E, Borja AJ, Gerke O, Werner TJ, Alavi A, Revheim ME (2019)
Assessing respitatory muscle activity with F-18-FDG-PET/CT in patients with COPD
Am. J. Nucl. Med. Molec. Imaging, 9 (6), 309-315

Muller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
Amyloid-beta PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer's disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365

Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2019)
Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Acta Radiol., 60 (8), 1028-1038
DOI 10.1177/0284185118810977

Publications 2018

Ausland L, Revheim ME, Skretting A, Stokke C (2018)
Respiratory motion during (90)Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
Acta Radiol., 59 (2), 132-139
DOI 10.1177/0284185117710052

de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrom T, Saugstad OD, Malinen E, Revheim ME (2018)
Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
Nucl. Med. Biol., 66, 49-57
DOI 10.1016/j.nucmedbio.2018.08.004

Grut H, Dueland S, Line PD, Revheim ME (2018)
The prognostic value of F-18-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur. J. Nucl. Med. Mol. Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9

Grut H, Revheim ME, Line PD, Dueland S (2018)
Importance of F-18-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl. Med. Commun., 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843

Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2018)
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br. J. Surg., 105 (3), 295-301
DOI 10.1002/bjs.10651

Halsne T, Muller EG, Spiten AE, Sherwani AG, Mikalsen LTG, Revheim ME, Stokke C (2018)
The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic F-18-FDG PET/CT
J. Nucl. Med. Technol., 46 (3), 253-259
DOI 10.2967/jnmt.117.204586

Tulipan AJ, Vlatkovic L, Malinen E, Brennhovd B, Hole KH, Lie AK, Ragnum HB, Revheim ME, Seierstad T (2018)
Comparison of time curves from dynamic F-18-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
Phys. Imag. Radiat. Oncol., 7, 51-57
DOI 10.1016/j.phro.2018.09.003

Publications 2015

Revheim ME, Haugvik SP, Johnsrud K, Mathisen O, Fjeld JG, Skretting A (2015)
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases
Acta Radiol., 56 (4), 397-403
DOI 10.1177/0284185114529563

Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sorensen K, Reier-Nilsen F, Revheim ME, Fjeld JG, Skjelland M, Russell D (2015)
Carotid plaque inflammation assessed with F-18-FDG PET/CT is higher in symptomatic compared with asymptomatic patients
Int. J. Stroke, 10 (5), 730-736
DOI 10.1111/ijs.12430

Publications 2014

Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2014)
Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
Acta Oncol., 53 (1), 143-148
DOI 10.3109/0284186X.2013.798428

Publications 2013

Floisand Y, Beiske K, Tjonnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin
Case Rep. Hematol., 2013, 934781
DOI 10.1155/2013/934781

Kristian A, Nilsen LB, Roe K, Revheim ME, Engebraten O, Mlandsmo GM, Holm R, Malinen E, Seierstad T (2013)
Dynamic F-18-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
NUCL. MED. MOLEC. IMAG., 47 (3), 173-180
DOI 10.1007/s13139-013-0211-y

Kristian A, Revheim ME, Qu H, Maelandsmo GM, Engebraten O, Seierstad T, Malinen E (2013)
Dynamic F-18-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
Acta Oncol., 52 (7), 1566-1572
DOI 10.3109/0284186X.2013.813634

Revheim ME, Kristian A, Malinen E, Bruland OS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
Acta Oncol., 52 (4), 776-782
DOI 10.3109/0284186X.2013.770920

Rusten E, Rodal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2013)
Quantitative dynamic (18)FDG-PET and tracer kinetic analysis of soft tissue sarcomas
Acta Oncol., 52 (6), 1160-1167
DOI 10.3109/0284186X.2012.728713

Skretting A, Revheim ME, Knudtsen IS, Johnsrud K, Bogsrud TV (2013)
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds
Acta Radiol., 54 (6), 672-675
DOI 10.1177/0284185113478007

Publications 2012

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A Man with Abdominal Pain: Enough Evidence for Surgery?
Clin. Chem., 58 (8), 1187-1190
DOI 10.1373/clinchem.2011.167015

Publications 2011

Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2011)
DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
Acta Oncol., 50 (1), 148-150
DOI 10.3109/0284186X.2010.516273

Revheim ME, Roe K, Bruland OS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT
Mol. Imaging. Biol., 13 (6), 1234-1240
DOI 10.1007/s11307-010-0464-0

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fossa SD, Lilleby W (2011)
Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma
Clin. Oncol., 23 (5), 339-343
DOI 10.1016/j.clon.2010.11.006

Publications 2009

Revheim ME, Seierstad T, Berner JM, Bruland OS, Roe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
Establishment and Characterization of a Human Gastrointestinal Stromal Tumour (GIST) Xenograft in Athymic Nude Mice
Anticancer Res., 29 (11), 4331-4336